Functionalisation of dental implant surfaces using organic and inorganic coatings
Funktionalisierung von dentalen Implantatoberflächen durch organische und anorganische Beschichtungen 1 Dept. of Oral and Maxillofacial Surgery, George-Augusta-University, Göttingen, Germany cur due to poor bone quality owing to local or general conditions. Several attempts have been made to improve the quality of the implant surface by various modifications in order to enhance periimplant bone formation and thereby increase the reliability of dental implants also in cases, in which local bone conditions are critical.
Calcium Phosphate coatings
The vast majority of dental implants are made of commercially pure titanium, a material that has proven its excellent biocompatibility also in many other applications and medical devices. The oldest and most widespread approach to increase the biocompatibility of commercially used titanium implants has been the use of Calcium Phosphate coatings on the implant surfaces. A large variety of techniques such as immersion and sinter coating, hot isostatic pressing, sputter coating and plasma flame spray coating have been employed [27] . Most of these coatings have been associated with an increased boneimplant contact or an improved ability to bridge periimplant bone gaps [9, 12, 18, 22, 58, 59] Problems associated with calcium phosphate coated implants have been a lack of long term stability of the coating layer and a layer thickness of 50 -100 µm. A non-homogenous composition of several calcium phosphate phases (CPP) within plasma sprayed coatings with a high content of amorphic calcium phosphate could lead to phase transition and result in tensile strains with fragmentation of the coating layer. Subsequent biologic attack in-vivo [10, 17, 24, 54, 55, 56, 58] after mechanical failure of the coatings has been associated with adverse tissue reactions during degradation of separated coating fragments [39, 45] . Refinements in the coating technique have increased the crystallinity of the calcium phosphate layer to improve its long term stability under in vivo conditions, but it is unclear, whether this increase in crystallinity leads to improved biological performance [11, 29, 37] .
In order to improve the biological behavior of Calcium Phosphate coatings new coating strategies have been developed and experimentally tested that produce much thinner coating layers [28, 33, 46, 53, 60] . These procedures have applied novel technologies such as electrostatic spray deposition, spark discharging, supersonic particle acceleration or magnetron sputtering and have shown to be equally effective as thicker coatings with respect to enhancement of early bone response [31, 32, 33] . Moreover, is has been shown recently, that degradation of these coatings is not detrimental to periimplant bone reactions [36] and can be even associated with increased osteoconductivity and enhanced bone-implant contact [60] . Finally, the simulation of the natural process of calcification on the surface of metal implants is an approach that could produce thinner coatings with improved biological performance. Coating procedures through precipitation of calcium and phosphate on titanium surfaces have resulted in mineral structures closer to bone than those obtained from plasma spray coatings [20] . Electrochemically assisted deposition of a thin hydroxyapatite layer has been produced on the titanium surfaces using cathodic polarization in a Calcium Phosphate solution under near physiological conditions [44] and subsequent anodization to increase the adhesion strength of the layer by partially integrating the hydroxyapatite crystals into the grown oxide layer [38] (Fig. 1b) . These coatings have shown to improve the bone implant contact on both Titanium alloy surfaces (Ti6Al4V) and commercially pure titanium implants with machined surfaces (Fig. 1a ) in dog mandibles [49, 52] . 
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Scanning electron microscopy (SEM) was performed with a Gemini electron microscope (Zeiss). 
Organic Coatings
A different road to enhanced biological performance of implant surfaces is taken by focusing on the organic components of the bone matrix to improve the biological interaction between implant surfaces and adjacent bone tissue. Organic coating of biomaterials has been widely used to enhance the biocompatibility of implanted materials. The coverage of scaffold materials with glycoproteins, collagens and matrix proteins such as laminin or fibronectin as well as synthetic polymers has been frequently applied either to increase the adhesion of cells for in-vitro engineering of tissues or to direct biological responses in-vivo [6, 7, 21, 25] . In many applications, organic molecules have been bound to the surface through adsorption by soaking the biomaterials with the respective solution. The fate of these coatings after insertion into an in vivo environment is unclear as rapid desorption from the surface may occur and limit the period of interaction with adjacent cells. Anchoring of organic molecules on a metallic surface will, therefore, be important to achieve a predictable quality for clinical applications.
Collagen I may be of particular interest for endosseous applications as it represents 90 % of the organic components of bone matrix and plays an important role in matrix assembly and coordination of mineralization. It is also crucial for cellular adhesion through the presentation of several binding sites for bone cells. Anchorage of collagen fibres on the surface of metal implants has been recently described using a two step electrochemical process with immersion of the implant into a collagen solution and subsequent integration into an anodically formed oxide layer on the implant surface [43, 50] (Fig. 2) . This surface has been found to enhance adhesion and differentiation of osteoblasts in vitro [3, 16] and to promote periimplant bone formation after 3 months in dog mandibles when compared to machined uncoated titanium surfaces [50] . The approach to enhancement of periimplant bone tissue formation has been developed further by using the knowledge that signal transduction is involved in the short term and long term adhesion of cells to biomaterial surfaces. This strategy that "involves employment of microstructures and functional domains of organismal tissue function to design and synthesize new materials for health applications" is called biomimetics [41] .
One important pathway through which cells interact with their environment are integrin receptors on the cell surface that mediate cell adhesion by binding to RGD motifs (a sequence of three amino acids Arg-Lys-Asp) presented in the vicinity of the cells [30, 34) . The attachment of bone cells to biomimetic peptide coated surfaces is mediated through different integrin subunits. Alpha2beta1 units mediate adhesion to collagen while alphavbeta3 and alphavbeta5 receptors bind to RGD motifs of bone specific proteins such as vitronectin, osteopontin and protegerin [19, 42] . Binding of RGD peptides to the integrin receptors initiates a cytoplasmatic signalling pathway to the nucleus that can alter cellular architecture or initiate cell migration and proliferation. Coating of implant surfaces with RGD motifs has resulted in significantly higher numbers of adhering cells [13, 35, 40] . RGD peptides have also shown to accelerate endothelial cell lining of synthetic fabrics in cardiovascular application [40] . Coating of inorganic carriers with RGD peptides in in-vitro studies with osteoblasts has resulted in adhesion of greater numbers of cells and increased mineralization on RGD covered surfaces [13, 19, 23, 47] . RGD peptides have been anchored to biomaterial surfaces in different ways. When bound directly to biomaterials, the presence and the length of a spacer molecule between the surface and the RGD motif appear to be important for the enhancement of cell adhesion [20, 47] . Direct anchorage of RGD peptides on the surface of metal implants has been accomplished through phosphonate and thiol anchors. [2, 14, 15, 26] . These coatings have resulted in increased bone ingrowth into fibre meshes in rabbit calvarial defects [26] and enhanced periimplant bone formation around plasma sprayed cylindrical implants in a canine model [14, 15] . RGD peptides have also been bound to collagen coated surfaces using acrylate anchors [48, 50] which resulted in increased bone implant contact and bone density during early stages of periimplant bone formation already after one month (Fig. 3a & b) In trying to complete the idea of stimulating bone reactions by mimicking bone tissue features using its functional domains and microstructures, Collagen I coating layers have been used as a basis for more complex coatings that include other components of bone matrix such as non-collagenous proteins and glycosaminoglycans. Recently, Bierbaum et al. (2006) have reported about the use of a mixture of collagen I and chondroitin sulphate (CS) for coating of titanium surfaces [4] . Collagen assembly was carried out together with CS by adsorption to titanium discs (Fig. 4) . Rat osteoblasts on CS containing
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Henning Schliephake: Functionalisation of dental implant surfaces using organic and inorganic coatings surfaces produced five times higher amounts of osteopontin, a marker for osteogenic differentiation. Additionally, recombinant human bone morphogenic protein 2 (rhBMP2) had been adsorbed to a Collagen I / CS layer by subsequent immersion into of a solution of 6.4 µl/ml rhBMP2 for 16 h [50] . The release of the adsorbed BMP from this coating is characterized by a burst release of activity within the first hours [5] . Despite a clear beneficial effect on osteoblastic differentiation of this coating in vitro, a significant enhancement of bone formation in vivo has not yet been clearly shown [51] . Refinements with respect to growth factors dosage and binding to a complex organic coating layer will be required to simulate the enhancing effect of bone matrix on new bone formation.
Mineralized organic coatings
The possibility to anchor collagen fibers on a titanium surface has opened up new perspectives also for the use of Calcium Phosphate coatings. The combination of Collagen I with the precipitation of Calcium Phosphates could produce an additive effect of both components by creating a structure and surface that even better resembles that of natural bone and therefore may be even more conducive to osteogenic cells. Mineralized collagen coatings have been fabricated on a hydroxyapatite base layer that was produced under cathodic polarization and near physiological conditions by adsorbing collagen fibrils to this layer with subsequent mineralization using the same electrochemically assisted process as for base layer deposition. The resulting thickness of this layer was app. 600 nm (Fig. 5) . Other than the morphology of the pure hydroxyapatite layer that is characterized by hydroxyapatite crystals with typical length of 300 nm and diameters of 60 nm (Fig.  1b) , this layer provided a surface layer that is formed by a network of completely mineralized collagen fibrils [52] . When tested in vivo these coatings have resulted in significantly increased bone implant contact compared to uncoated smooth titanium surfaces already after one month and significantly increased periimplant bone density when compared even to an non-mineralized Collagen I coating [52] .
Concluding remarks
Functionalisation of titanium surfaces of endosseous dental implants has been accomplished through a number of approaches. Both organic and inorganic coatings have shown clear advantages in vitro with respect to proliferation and differentiation of osteoblasts or osteoblasts like cells. These effects have been visible also in the in vivo environment, but not with the same consistence and clarity. One reason for a blurred picture may be the fact that the fate of the biomimetic coatings under in vivo conditions is not clear yet. Collagen coatings may be rapidly dissolved by matrix degrading enzymes such as collagenases and matrixmetalloproteinases (MMPs). The longevity of Calcium Phosphate coatings may be affected by dissolution during early stages of implant healing which is promoted by differences in chemical composition and an acidic environment [57] . However, degradation of biomimetic Calcium Phosphate coatings has shown no negative effect on bone behavior in vivo [28] . The in vivo results of coatings that use biological signals such as RGD peptides or growth factors could be affected by the complexity of signals that have an effect on osteoprogenitor cells during periimplant wound healing. Signal intensity on the biomaterial surface that is able to induce a cellular response under in vitro conditions may not be recognisable in vivo due to higher intensities of conflicting signals originating from wound fluids and adjacent natural organic components. The initial interaction between a titanium surface and its in vivo environment is characterised by the rapid adsorption of plasma proteins and extracellular matrix components. Many of these proteins either present binding sites themselves or may prevent binding of cells by spatial interference between the signals located in the coated implant surface and the approaching osteoprogenitor cells. This is more likely to happen under healthy and viable periimplant bone conditions. The value of functionalized implant surfaces in vivo, therefore, could become even clearer in experimental models that provide compromised bone conditions due to osteoporosis or preceding radiotherapy. In this environment, where the regenerative potential and the vascularity of the surrounding bone are reduced, enhancement of bone regeneration by functionalized implant surfaces may become more appreciable. In conclusion, current approaches to functionalisation of implant surfaces for endosseous use have shown considerable potential to enhance periimplant bone formation in vivo. They provide a solid body of positive preclinical results in non-diseased animal models. In order to prove their clinical potential in compromised bone, they should also be tested in animal models that provide compromised bone conditions.
Abstract
The clinical success of endosseous implants is based on an intimate bone implant contact that provides reliable long term stability. Compromised bone conditions due to local or systemic diseases can lead to inferior periimplant bone formation and thereby jeopardize the clinical success. Several strategies have been developed to increase the biological quality of implant surfaces in order to improve the anchorage of implants in bone tissue. New thin Calcium Phosphate coatings have been able to solve the problem of increased coating thickness and subsequent long term problems due to delamination without loosing the enhancing effect on periimplant bone formation. Novel organic coating technologies have integrated Collagen I fibers to titanium surfaces and thereby improved bone formation. Binding of RGD motifs to titanium surfaces and organic coatings using various anchoring molecules have resulted in increased bone implant contact and periimplant bone density. Finally, combined coating strategies using simultaneous deposition of Calcium Phosphates and Collagen I have shown to enhance bone formation around these implants. All these studies provide a solid body of positive preclinical results in non-diseased animal models. In order to prove their clinical potential in diseased bone, they should also be tested in animal models that provide compromised bone conditions.
